CA Stock MarketDetailed Quotes

Knight Therapeutics Inc (GUD)

Watchlist
  • 7.540
  • -0.010-0.13%
15min DelayTrading May 6 13:29 ET
739.34MMarket Cap-150.80P/E (TTM)

Knight Therapeutics Inc (GUD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
90.07%68.96M
2,273.86%34.87M
102.61%10.16M
1,964.83%20.25M
-88.12%3.67M
0.95%36.28M
-91.81%1.47M
-66.93%5.02M
26.92%-1.09M
615.50%30.88M
Net income from continuing operations
-224.05%-5.37M
-17.52%8.85M
-4,560.00%-3.79M
-549.95%-12.62M
148.06%2.19M
125.73%4.33M
144.13%10.74M
-99.11%85K
-205.54%-1.94M
-15.47%-4.55M
Operating gains losses
1,261.13%3.7M
36.26%-8.82M
106.03%6.01M
63.65%-1.5M
-83.82%2.28M
-101.81%-319K
-200.83%-13.84M
250.18%2.92M
13.14%-4.12M
32.74%14.06M
Depreciation and amortization
6.51%56.57M
7.94%15.08M
32.71%17.77M
-7.83%12.14M
-7.92%11.58M
5.38%53.11M
21.92%13.97M
-2.26%13.39M
8.32%13.17M
-3.84%12.58M
Asset impairment expenditure
----
----
----
----
----
--0
----
----
----
----
Unrealized gains and losses of investment securities
----
----
----
762.71%5.74M
----
----
----
----
--665K
----
Remuneration paid in stock
336.24%8.11M
683.07%2.93M
104.87%1.64M
141.10%2.53M
98.43%1.01M
-20.07%1.86M
-236.78%-502K
129.51%801K
26.93%1.05M
-34.87%510K
Deferred tax
-17.51%-3.81M
171.88%2.59M
87.98%-161K
-321.42%-3.12M
26.90%-3.12M
64.46%-3.24M
137.40%953K
25.69%-1.34M
184.89%1.41M
-36.98%-4.27M
Other non cashItems
4,664.24%7.86M
2.58%2.42M
-48.05%80K
564.34%4.1M
142.47%1.26M
-98.40%165K
-49.94%2.36M
-93.87%154K
-50.24%617K
-261.87%-2.97M
Change In working capital
109.65%1.89M
196.82%11.82M
-3.58%-11.39M
208.84%12.99M
-174.33%-11.53M
29.95%-19.62M
-330.78%-12.21M
-51.93%-10.99M
-7.08%-11.93M
203.91%15.51M
-Change in receivables
-157.89%-26.53M
-177.42%-9.37M
-115.11%-19.77M
1,418.74%15.16M
-1,078.86%-12.55M
-284.54%-10.29M
-87.10%-3.38M
-153.52%-9.19M
-49.44%998K
110.90%1.28M
-Change in inventory
-201.52%-17.82M
35.55%7.04M
149.65%4.79M
268.75%9.54M
-1,034.92%-39.19M
-946.85%-5.91M
-71.71%5.19M
25.59%-9.64M
-172.66%-5.66M
259.63%4.19M
-Change in prepaid assets
129.55%1.28M
207.74%2.35M
71.97%-957K
-154.02%-933K
277.22%817K
32.67%-4.33M
74.54%-2.18M
-226.70%-3.41M
3,077.59%1.73M
-114.20%-461K
-Change in payables and accrued expense
1,061,225.00%42.45M
182.06%9.45M
-63.25%4.14M
-3.63%-9.93M
294.70%38.79M
99.98%-4K
-718.41%-11.52M
284.84%11.27M
46.81%-9.58M
260.10%9.83M
-Change in other current liabilities
177.06%2.52M
828.48%2.35M
2,656.25%409K
-245.70%-848K
-8.68%610K
118.01%911K
74.65%-323K
99.63%-16K
-91.73%582K
110.26%668K
Cash from discontinued investing activities
Operating cash flow
90.07%68.96M
2,273.86%34.87M
102.61%10.16M
1,964.83%20.25M
-88.12%3.67M
0.95%36.28M
-91.81%1.47M
-66.93%5.02M
26.92%-1.09M
615.50%30.88M
Investing cash flow
Cash flow from continuing investing activities
-543.07%-75.16M
-125.40%-4.58M
-112.20%-1.41M
-961.86%-101.29M
231.85%32.13M
-42.19%16.96M
1,049.45%18.05M
-67.76%11.53M
179.83%11.75M
-179.62%-24.37M
Net PPE purchase and sale
20.73%-1.88M
-9.78%-505K
-9.63%-410K
9.49%-620K
59.65%-343K
-343.22%-2.37M
-131.02%-460K
-64.76%-374K
-333.54%-685K
-585.48%-850K
Net intangibles purchas and sale
-9.60%-31.79M
-200.78%-1.55M
-43.69%-2.4M
-46.45%-24.51M
66.99%-3.33M
-221.97%-29M
59.80%-515K
-2,685.00%-1.67M
---16.74M
-31.50%-10.08M
Net business purchase and sale
---110.08M
--0
---3.2M
---106.89M
----
--0
--0
--0
--0
--0
Net investment purchase and sale
5.70%50.99M
-113.30%-2.53M
-94.39%761K
-41.86%16.96M
364.56%35.8M
251.13%48.24M
246.72%19.02M
-52.59%13.57M
3,020.22%29.17M
-313.79%-13.53M
Dividends received (cash flow from investment activities)
----
----
----
----
----
----
----
----
----
--581K
Net other investing changes
18,042.27%17.6M
--0
--3.84M
--13.76M
----
-99.59%97K
--0
----
----
--97K
Cash from discontinued investing activities
Investing cash flow
-543.07%-75.16M
-125.40%-4.58M
-112.20%-1.41M
-961.86%-101.29M
231.85%32.13M
-42.19%16.96M
1,049.45%18.05M
-67.76%11.53M
179.83%11.75M
-179.62%-24.37M
Financing cash flow
Cash flow from continuing financing activities
116.12%5.41M
-126.64%-34.8M
-50.47%-5.91M
547.21%50.81M
-62.20%-4.7M
58.59%-33.54M
56.99%-15.35M
65.06%-3.93M
48.58%-11.36M
75.60%-2.9M
Net issuance payments of debt
213.71%20.53M
-267.88%-27.3M
-258.37%-5.01M
846.87%53.51M
56.49%-899K
-0.15%-18.05M
38.63%-7.42M
-117.08%-1.4M
-61.34%-7.17M
-144.50%-2.07M
Net common stock issuance
28.36%-6.35M
41.73%-3M
--0
99.52%-6K
---3.35M
83.42%-8.87M
73.01%-5.15M
74.84%-2.47M
91.10%-1.24M
--0
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
-49.00%511K
-5.00%133K
-71.88%126K
-59.41%138K
54.05%114K
163.68%1M
47.37%140K
409.09%448K
223.81%340K
-19.57%74K
Interest paid (cash flow from financing activities)
0.28%-7.6M
-1.03%-2.95M
-103.78%-1.03M
7.19%-3.06M
37.13%-569K
22.82%-7.63M
36.70%-2.92M
40.82%-503K
13.47%-3.3M
-49.59%-905K
Net other financing activities
---1.67M
----
----
--225K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
116.12%5.41M
-126.64%-34.8M
-50.47%-5.91M
547.21%50.81M
-62.20%-4.7M
58.59%-33.54M
56.99%-15.35M
65.06%-3.93M
48.58%-11.36M
75.60%-2.9M
Net cash flow
Beginning cash position
36.33%80.11M
11.01%81.88M
27.97%77.82M
78.49%112.16M
36.33%80.11M
-18.02%58.76M
-4.73%73.76M
60.68%60.81M
11.77%62.84M
-18.02%58.76M
Current changes in cash
-104.03%-795K
-208.31%-4.51M
-77.43%2.85M
-4,249.64%-30.23M
759.51%31.1M
225.32%19.7M
121.18%4.16M
-68.21%12.62M
96.41%-695K
122.24%3.62M
Effect of exchange rate changes
-274.30%-2.86M
-141.93%-917K
265.06%1.21M
-208.25%-4.11M
108.77%952K
-41.44%1.64M
118.92%2.19M
404.59%332K
-232.37%-1.33M
-43.63%456K
End cash Position
-4.57%76.45M
-4.57%76.45M
11.01%81.88M
27.97%77.82M
78.49%112.16M
36.33%80.11M
36.33%80.11M
-4.73%73.76M
60.68%60.81M
11.77%62.84M
Free cash from
633.42%35.26M
8,229.44%32.82M
147.46%7.35M
73.66%-4.88M
-100.16%-31K
-81.49%4.81M
-97.57%394K
-80.03%2.97M
-1,025.85%-18.51M
672.40%19.89M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 90.07%68.96M2,273.86%34.87M102.61%10.16M1,964.83%20.25M-88.12%3.67M0.95%36.28M-91.81%1.47M-66.93%5.02M26.92%-1.09M615.50%30.88M
Net income from continuing operations -224.05%-5.37M-17.52%8.85M-4,560.00%-3.79M-549.95%-12.62M148.06%2.19M125.73%4.33M144.13%10.74M-99.11%85K-205.54%-1.94M-15.47%-4.55M
Operating gains losses 1,261.13%3.7M36.26%-8.82M106.03%6.01M63.65%-1.5M-83.82%2.28M-101.81%-319K-200.83%-13.84M250.18%2.92M13.14%-4.12M32.74%14.06M
Depreciation and amortization 6.51%56.57M7.94%15.08M32.71%17.77M-7.83%12.14M-7.92%11.58M5.38%53.11M21.92%13.97M-2.26%13.39M8.32%13.17M-3.84%12.58M
Asset impairment expenditure ----------------------0----------------
Unrealized gains and losses of investment securities ------------762.71%5.74M------------------665K----
Remuneration paid in stock 336.24%8.11M683.07%2.93M104.87%1.64M141.10%2.53M98.43%1.01M-20.07%1.86M-236.78%-502K129.51%801K26.93%1.05M-34.87%510K
Deferred tax -17.51%-3.81M171.88%2.59M87.98%-161K-321.42%-3.12M26.90%-3.12M64.46%-3.24M137.40%953K25.69%-1.34M184.89%1.41M-36.98%-4.27M
Other non cashItems 4,664.24%7.86M2.58%2.42M-48.05%80K564.34%4.1M142.47%1.26M-98.40%165K-49.94%2.36M-93.87%154K-50.24%617K-261.87%-2.97M
Change In working capital 109.65%1.89M196.82%11.82M-3.58%-11.39M208.84%12.99M-174.33%-11.53M29.95%-19.62M-330.78%-12.21M-51.93%-10.99M-7.08%-11.93M203.91%15.51M
-Change in receivables -157.89%-26.53M-177.42%-9.37M-115.11%-19.77M1,418.74%15.16M-1,078.86%-12.55M-284.54%-10.29M-87.10%-3.38M-153.52%-9.19M-49.44%998K110.90%1.28M
-Change in inventory -201.52%-17.82M35.55%7.04M149.65%4.79M268.75%9.54M-1,034.92%-39.19M-946.85%-5.91M-71.71%5.19M25.59%-9.64M-172.66%-5.66M259.63%4.19M
-Change in prepaid assets 129.55%1.28M207.74%2.35M71.97%-957K-154.02%-933K277.22%817K32.67%-4.33M74.54%-2.18M-226.70%-3.41M3,077.59%1.73M-114.20%-461K
-Change in payables and accrued expense 1,061,225.00%42.45M182.06%9.45M-63.25%4.14M-3.63%-9.93M294.70%38.79M99.98%-4K-718.41%-11.52M284.84%11.27M46.81%-9.58M260.10%9.83M
-Change in other current liabilities 177.06%2.52M828.48%2.35M2,656.25%409K-245.70%-848K-8.68%610K118.01%911K74.65%-323K99.63%-16K-91.73%582K110.26%668K
Cash from discontinued investing activities
Operating cash flow 90.07%68.96M2,273.86%34.87M102.61%10.16M1,964.83%20.25M-88.12%3.67M0.95%36.28M-91.81%1.47M-66.93%5.02M26.92%-1.09M615.50%30.88M
Investing cash flow
Cash flow from continuing investing activities -543.07%-75.16M-125.40%-4.58M-112.20%-1.41M-961.86%-101.29M231.85%32.13M-42.19%16.96M1,049.45%18.05M-67.76%11.53M179.83%11.75M-179.62%-24.37M
Net PPE purchase and sale 20.73%-1.88M-9.78%-505K-9.63%-410K9.49%-620K59.65%-343K-343.22%-2.37M-131.02%-460K-64.76%-374K-333.54%-685K-585.48%-850K
Net intangibles purchas and sale -9.60%-31.79M-200.78%-1.55M-43.69%-2.4M-46.45%-24.51M66.99%-3.33M-221.97%-29M59.80%-515K-2,685.00%-1.67M---16.74M-31.50%-10.08M
Net business purchase and sale ---110.08M--0---3.2M---106.89M------0--0--0--0--0
Net investment purchase and sale 5.70%50.99M-113.30%-2.53M-94.39%761K-41.86%16.96M364.56%35.8M251.13%48.24M246.72%19.02M-52.59%13.57M3,020.22%29.17M-313.79%-13.53M
Dividends received (cash flow from investment activities) --------------------------------------581K
Net other investing changes 18,042.27%17.6M--0--3.84M--13.76M-----99.59%97K--0----------97K
Cash from discontinued investing activities
Investing cash flow -543.07%-75.16M-125.40%-4.58M-112.20%-1.41M-961.86%-101.29M231.85%32.13M-42.19%16.96M1,049.45%18.05M-67.76%11.53M179.83%11.75M-179.62%-24.37M
Financing cash flow
Cash flow from continuing financing activities 116.12%5.41M-126.64%-34.8M-50.47%-5.91M547.21%50.81M-62.20%-4.7M58.59%-33.54M56.99%-15.35M65.06%-3.93M48.58%-11.36M75.60%-2.9M
Net issuance payments of debt 213.71%20.53M-267.88%-27.3M-258.37%-5.01M846.87%53.51M56.49%-899K-0.15%-18.05M38.63%-7.42M-117.08%-1.4M-61.34%-7.17M-144.50%-2.07M
Net common stock issuance 28.36%-6.35M41.73%-3M--099.52%-6K---3.35M83.42%-8.87M73.01%-5.15M74.84%-2.47M91.10%-1.24M--0
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Proceeds from stock option exercised by employees -49.00%511K-5.00%133K-71.88%126K-59.41%138K54.05%114K163.68%1M47.37%140K409.09%448K223.81%340K-19.57%74K
Interest paid (cash flow from financing activities) 0.28%-7.6M-1.03%-2.95M-103.78%-1.03M7.19%-3.06M37.13%-569K22.82%-7.63M36.70%-2.92M40.82%-503K13.47%-3.3M-49.59%-905K
Net other financing activities ---1.67M----------225K------------------------
Cash from discontinued financing activities
Financing cash flow 116.12%5.41M-126.64%-34.8M-50.47%-5.91M547.21%50.81M-62.20%-4.7M58.59%-33.54M56.99%-15.35M65.06%-3.93M48.58%-11.36M75.60%-2.9M
Net cash flow
Beginning cash position 36.33%80.11M11.01%81.88M27.97%77.82M78.49%112.16M36.33%80.11M-18.02%58.76M-4.73%73.76M60.68%60.81M11.77%62.84M-18.02%58.76M
Current changes in cash -104.03%-795K-208.31%-4.51M-77.43%2.85M-4,249.64%-30.23M759.51%31.1M225.32%19.7M121.18%4.16M-68.21%12.62M96.41%-695K122.24%3.62M
Effect of exchange rate changes -274.30%-2.86M-141.93%-917K265.06%1.21M-208.25%-4.11M108.77%952K-41.44%1.64M118.92%2.19M404.59%332K-232.37%-1.33M-43.63%456K
End cash Position -4.57%76.45M-4.57%76.45M11.01%81.88M27.97%77.82M78.49%112.16M36.33%80.11M36.33%80.11M-4.73%73.76M60.68%60.81M11.77%62.84M
Free cash from 633.42%35.26M8,229.44%32.82M147.46%7.35M73.66%-4.88M-100.16%-31K-81.49%4.81M-97.57%394K-80.03%2.97M-1,025.85%-18.51M672.40%19.89M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report by AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has bee Show More